Most Profitable Pharmaceutical Products Companies
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Net Income
| Net Income | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | MEIP | MEI Pharma | (0.05) | 2.62 | (0.14) | ||
| 2 | SNYR | SYNERGY CHC P | 0.28 | 257.65 | 73.33 | ||
| 3 | MIRA | MIRA Pharmaceuticals, Common | (0.04) | 7.62 | (0.33) | ||
| 4 | TVGNW | Tevogen Bio Holdings | 0.17 | 26.28 | 4.46 | ||
| 5 | REVBW | Revelation Biosciences | 0.02 | 9.82 | 0.22 | ||
| 6 | VCEL | Vericel Corp Ord | 0.09 | 3.06 | 0.27 | ||
| 7 | DWTX | Dogwood Therapeutics, | (0.03) | 11.55 | (0.36) | ||
| 8 | CYCCP | Cyclacel Pharmaceuticals | (0.10) | 4.39 | (0.43) | ||
| 9 | CLYM | Climb Bio | (0.17) | 5.43 | (0.93) | ||
| 10 | ZBIO | Zenas BioPharma, Common | (0.16) | 5.81 | (0.93) | ||
| 11 | CAMP | CAMP4 THERAPEUTICS PORATION | (0.19) | 8.77 | (1.65) | ||
| 12 | PLRZ | Polyrizon Ltd Ordinary | (0.20) | 10.88 | (2.14) | ||
| 13 | UPB | Upstream Bio, | 0.05 | 7.43 | 0.40 | ||
| 14 | NWBO | Northwest Biotherapeutics | (0.11) | 3.69 | (0.41) | ||
| 15 | XOMAP | XOMA Corp | 0.07 | 0.77 | 0.05 | ||
| 16 | XOMAO | XOMA Corporation | 0.12 | 0.41 | 0.05 | ||
| 17 | CEROW | CERo Therapeutics Holdings | 0.16 | 38.62 | 6.09 | ||
| 18 | GELS | Gelteq Limited Ordinary | (0.34) | 8.79 | (3.00) | ||
| 19 | SLXNW | Biomotion Sciences Warrant | 0.06 | 31.20 | 1.92 | ||
| 20 | DVAX | Dynavax Technologies | 0.06 | 2.48 | 0.14 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.